| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 06/30/2004 | CN1509165A Liquid pharmaceutical composition |
| 06/30/2004 | CN1507918A Transdermal promotor glycerin triacetate |
| 06/30/2004 | CN1155571C Gamma-glutamyl and beta-aspartyl containing immunomodulator compounds and methods therewith |
| 06/29/2004 | US6756480 Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein |
| 06/29/2004 | US6756391 Antiviral compounds |
| 06/29/2004 | US6756372 For therapy of autoimmune diseases, alzheimer's disease, atherosclerosis, osteoporosis, rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, ulcerative colitis, multiple sclerosis, guillain-barre syndrome, psoriasis |
| 06/29/2004 | CA2263913C Substituted 6,6-hetero-bicyclic derivatives |
| 06/24/2004 | WO2004052888A2 Tropane esters and methods for producing and using them |
| 06/24/2004 | WO2004052863A1 Anti-inflammatory agent |
| 06/24/2004 | WO2004052381A1 An organic extract of geum japonicum thumb variant and use thereof |
| 06/24/2004 | WO2004022716A3 Recombinatant mutants of rhabdovirus and methods of use thereof |
| 06/24/2004 | WO2004014304A3 Electrospun amorphous pharmaceutical compositions |
| 06/24/2004 | WO2003103583A3 A method for using tethered bis(polyhydroxyphenyls) and o-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 06/24/2004 | WO2003051841A3 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 06/24/2004 | WO2003047589A8 Pharmaceutical compositions containing 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission |
| 06/24/2004 | WO2003018044A8 New drug |
| 06/24/2004 | US20040122034 Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-1yl)acetamide |
| 06/24/2004 | US20040121962 Prodrugs of excitatory amino acids |
| 06/24/2004 | US20040121446 Induction of gene expression using a high concentration sugar mixture |
| 06/23/2004 | EP1431285A1 Reverse hydroxamic acid derivatives |
| 06/23/2004 | EP1430114A2 Prolactin induced increase in neural stem cell numbers and therapeutical use thereof |
| 06/23/2004 | EP1430056A1 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders |
| 06/23/2004 | EP1429800A2 Vaccine and method for treatment of motor neurone diseases |
| 06/23/2004 | EP1429779A2 Androstanes as androgen receptor modulators |
| 06/23/2004 | EP1429767A1 Acylic piperazine and piperidine derivatives which are useful for treating neuronal damage |
| 06/23/2004 | EP1429752A1 Neuroprotective treatment methods using selective inos inhibitors |
| 06/23/2004 | EP1429750A2 Inhibition by 3-deoxyflavonoids of t-lymphocyte activation and therapies related thereto |
| 06/23/2004 | EP1429727A1 Apoptosis-mimicking synthetic entities and use thereof in medical treatment |
| 06/23/2004 | EP1429617A2 Methods for sterilizing preparations of digestive enzymes |
| 06/23/2004 | EP1252157B1 Pyrimidine carboxamides useful as inhibitors of pde4 isozymes |
| 06/23/2004 | EP1230227B1 Benzoxa-and benzothiazolyl sulfamates and their use as steroid sulfatase inhibitors |
| 06/23/2004 | CN1507437A Aralkylpiperazines with serotonin 5-HTIA activity |
| 06/23/2004 | CN1154490C Celecoxib compositions |
| 06/23/2004 | CN1154489C Heterocyclic vinylethers against neurological disorders |
| 06/22/2004 | US6753332 Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 06/17/2004 | WO2004050116A1 Protease inhibitor |
| 06/17/2004 | WO2004050114A1 Novel agent for improving neurotransmission failure |
| 06/17/2004 | WO2004050088A1 Jnk inhibitor |
| 06/17/2004 | WO2004050076A1 Use of a histone deacetylase inhibitor for treating muscular dystrophies |
| 06/17/2004 | WO2004049830A1 Sustained improver of muscular fatigue |
| 06/17/2004 | WO2004003164A3 Methods of organ regeneration |
| 06/17/2004 | WO2003106660A3 Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 06/17/2004 | WO2003026566A3 Atlastin |
| 06/17/2004 | US20040116703 Central nervous system disorders, nicotinic acetylcholine receptors; endocrine diseases; antiinflammatory agents; analgesics; drug dependency; skin disorders; Alzheimer's and Parkinson's disease |
| 06/17/2004 | US20040116697 Novel compounds |
| 06/17/2004 | US20040116507 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/17/2004 | US20040116472 inhibit angiogenesis, tumor metastasis and growth, osteoporosis, Paget's disease, hypercalcemia of malignancy, retinopathy, macular degeneration, arthritis, periodontal disease, smooth muscle cell migration and viral diseases |
| 06/17/2004 | US20040116446 Nitrogen compounds having improved solubility, bioavailability and stability, used as sedatives, anxiolytics, anticonvulsant, and/ or muscle relaxants for prophylaxis of sleep disorders |
| 06/17/2004 | US20040116431 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 06/17/2004 | US20040116424 Aryl imidazoles and related compounds as C5a receptor modulators |
| 06/17/2004 | US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 06/17/2004 | US20040115761 Polypeptides and nucleic acids encoding same |
| 06/17/2004 | US20040115261 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 06/17/2004 | US20040115139 Botulinum toxin dental therapies and procedures |
| 06/17/2004 | CA2508319A1 Jnk inhibitors |
| 06/17/2004 | CA2507450A1 Use of a histone deacetylase inhibitor for treating muscular dystrophies |
| 06/17/2004 | CA2485957A1 Protease inhibitor |
| 06/16/2004 | EP1428820A1 Non-imidazole alkylamines as histamine H-3-receptor ligands and their therapeutic applications |
| 06/16/2004 | EP1427857A2 Mid 4460, a human tyrosine phosphatase family member and uses therefor |
| 06/16/2004 | EP1427841A2 Nucleic acid-associated proteins |
| 06/16/2004 | EP1427722A2 Pyrrole-type compounds, compositions, and methods for treating cancer, treating viral diseases and causing immunosuppression |
| 06/16/2004 | EP1427708A1 Amino-phthalazinone derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 06/16/2004 | EP1427425A1 Method of treatment of obesity and paralyzed muscle and ergogenic aids |
| 06/16/2004 | EP1427412A1 Methods of treating cytokine mediated diseases |
| 06/16/2004 | EP1339719B1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 06/16/2004 | EP1214075B1 POLYMORPHS OF N-METHYL-N-(3- 3- 2-THIENYLCARBONYL]-PYRAZOL- 1,5-$g(a)]-PYRIMIDIN-7-YL PHENYL)ACETAMIDE AND COMPOSITIONS AND METHODS RELATED THERETO |
| 06/16/2004 | EP0983243B1 Novel quinoline- and naphthalenecarboxamides, pharmaceutical compositions and methods of inhibiting calpain |
| 06/16/2004 | EP0979079B1 Use of tetrahydropyridine derivatives to prepare medicines for treating diseases causing demyelination |
| 06/16/2004 | CN1505640A T cell receptor Vbeta-Dbeta-Jbeta sequence and methods for its detection |
| 06/16/2004 | CN1505638A Protection and enhancement of erythropoietin-responsive cells, tissues and organs |
| 06/16/2004 | CN1505627A Cyclic amp-specific phosphodiesterase inhibitors |
| 06/16/2004 | CN1505618A Dimeric isoflavones |
| 06/15/2004 | US6750202 Inhibitors of procollagen c-proteinase (pcp), for treating fibrosis of the liver |
| 06/15/2004 | US6750194 Administering to the subject a safe and effective amount of a vpac receptor agonist selected from the group consisting of ro 25-1553, and pacap-38 |
| 06/15/2004 | US6749851 Applying radiation |
| 06/15/2004 | US6749587 Modular infusion device and method |
| 06/10/2004 | WO2004048574A1 Immunoreceptor proteins |
| 06/10/2004 | WO2004048570A1 ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR |
| 06/10/2004 | WO2004048512A2 Novel proteins and nucleic acids encoding same |
| 06/10/2004 | WO2003101950A3 Methods for enhancing motor performance and/or endurance |
| 06/10/2004 | WO2003083039A8 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 06/10/2004 | WO2003070970A3 RNA INTERFERENCE MEDIATED INHIBITION OF NF-KAPPA B/REL-A GENE EXPRESSION USING SHORT INTERFEREING NUCLEIC ACID (siNA) |
| 06/10/2004 | WO2003048116A3 Esters and amides as ppar-alpha agonists ____________ |
| 06/10/2004 | WO2003037258A3 Methods and compositions for the treatment and diagnosis of pain disorders using 2047 |
| 06/10/2004 | US20040110952 e.g., N-[1-(3-phenyl-3-[cyclopenytlacetylamino]propyl)-4-piperidinyl]-N-ethyl-4-methanesulfonylphenylacetamide |
| 06/10/2004 | US20040110810 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 06/10/2004 | US20040110759 Inhibitors of IkB kinase (I Kappa B Kinase); treating various diseases including asthma, osteoarthritis, rheumatoid arthritis, Alzheimer's disease, cancer, infections, and cardiac infarct |
| 06/10/2004 | US20040110744 1 2 3 4 Tetrahydroisoquinolines derivatives as urotensin II receptor antagonists |
| 06/10/2004 | US20040110706 Nucleic acid with point mutations, deletions, insertions and/or rearrangements ; hyperthermia, myasthenia, ataxia, neuropathic and inflammatory pain; Alzheimer*s, Parkinson's disease; schizophrenia, hyperekplexia, myotonias and arrhythmia |
| 06/10/2004 | US20040110180 Comprises enzymatic polypeptide for diagnosis, treatment and prevention of cardiovascular, immune system, nervous system, lipid and cell proliferative disorders; drug screening |
| 06/10/2004 | US20040109907 Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 06/10/2004 | US20040109847 Treatment and prophylaxis with 4-1BB-binding agents |
| 06/10/2004 | CA2796924A1 Ena nucleic acid pharmaceuticals capable of modifying splicing of mrna precursors |
| 06/10/2004 | CA2507125A1 Ena nucleic acid pharmaceuticals capable of modifying splicing of mrna precursors |
| 06/09/2004 | EP1426375A2 Analgesic spiroindole derivatives |
| 06/09/2004 | EP1426050A1 Jnk inhibitors |
| 06/09/2004 | EP1425289A2 Novel nucleic acid and polypeptide molecules |
| 06/09/2004 | EP1425020A1 Methods and compositions for treating apoptosis associated disorders |
| 06/09/2004 | EP1425019A1 Pharmaceutical composition |
| 06/09/2004 | EP1425001A1 Phenethanolamine derivatives for treatment of respiratory diseases |